Udaipur: Generally, it is observed that when plasma is required, whole plasma (FFP) is transfused to patients, even though only a specific component may be needed. This often results in less benefit and more harm to the patient. To address this issue, Saral Blood Bank has installed a Cryoprecipitate machine, through which blood is separated into individual components so that only the required component is given to the patient, while the remaining components can be used for other needy patients.
Saral Blood Bank has become the first blood center to install such a machine.
In this context, a workshop on the increasing utility of “Cryoprecipitate” in blood components for effective patient treatment was organized at the Saral Blood Center auditorium in the presence of renowned doctors from the city. This workshop was conducted as a follow-up and implementation of in-depth discussions held during a state-level workshop on “Advances in Transfusion Medicine”, organized by Saral Sanstha in September 2025, with the objective of spreading awareness among medical professionals and the general public.
At the beginning of the program, Honorary Secretary of Saral Sanstha, CA (Dr.) Shyam S. Singhi, welcomed all participants. He informed that Saral Blood Center, which has been serving for over 17 years, has the distinction of being Southern Rajasthan’s first blood center to receive a license for preparing all types of blood components, including Cryoprecipitate. For this purpose, the institution has procured a state-of-the-art “Remi Make” thawing bath machine.
Despite continuous efforts by the blood bank, Cryoprecipitate had not been optimally utilized in patient treatment, while FFP continued to be preferred, resulting in the transfusion of unnecessary factors into patients’ bodies, which could sometimes cause harm.
Dr. Singhi expressed gratitude to Blood Bank In-charge Dr. Narendra Mogra and his entire team for their dedicated efforts in promoting the importance of Cryoprecipitate in society. He expressed hope that doctors would increasingly adopt Cryoprecipitate in clinical practice.
While elaborating on the effective use of Cryoprecipitate, Dr. Narendra Mogra, through a PowerPoint presentation, explained that Cryoprecipitate contains high concentrations of fibrinogen, coagulation factors VIII and XIII, von Willebrand factor, and fibronectin, while having a lower protein content. The volume of Cryoprecipitate is only 15 ml. It is especially useful in cases of massive bleeding, DIC (Disseminated Intravascular Coagulation), surgical or accidental trauma, and kidney failure.
In contrast, the use of FFP introduces unnecessary proteins and clotting factors, which may be harmful to patients.
Dr. Mogra further stated that because FFP has a volume of around 180 ml, it poses a higher risk of circulatory overload, especially in children and elderly patients. Cryoprecipitate is also more cost-effective than FFP, and due to its smaller volume, ABO compatibility is not required. Therefore, he strongly advocated that Cryoprecipitate should be given priority in patient treatment.
Co-Secretary of Saral Sanstha, Sanyam Singhi, informed that several senior doctors, including Dr. B.S. Bamb, Transfusion Medicine Specialist Dr. Sanjay Prakash, Medical Oncologist Dr. Sachin Jain, Gynecologist Dr. N.K. Joshi, Dr. Kalpesh Chaudhary, and Dr. Vinod Porwal, shared their views during the discussion. All emphasized the maximum possible use of Cryoprecipitate and congratulated Saral Blood Center for this pioneering initiative.
On this occasion, Sanyam Singhi also highlighted that the long-term association of dedicated staff has always been a hallmark of Saral Sanstha, helping it maintain a strong presence in society. He mentioned that Medical Officer Dr. Suresh Dangi and Medical Officer Dr. Pranshu Sharma, who had been serving the Blood Center for several years, were given a respectful farewell due to unavoidable circumstances.
The program concluded with a vote of thanks to all those present.